We are live on
!
Find out more
CRISPR Therapeutics
CRSP
CRSP
488 hedge funds and large institutions have $3.67B invested in CRISPR Therapeutics in 2026 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 175 increasing their positions, 116 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
51% more repeat investments, than reductions
Existing positions increased: 175 | Existing positions reduced: 116
39% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 57
21% more call options, than puts
Call options by funds: $127M | Put options by funds: $105M
2% more funds holding
Funds holding: 479 → 488 (+9)
0.1% more ownership
Funds ownership: 80.26% → 80.36% (+0.1%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
9% less capital invested
Capital invested by funds: $4.03B → $3.67B (-$357M)
Holders
488
Holders Change
+9
Holders Change %
+1.88%
% of All Funds
6.01%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
79
Increased
175
Reduced
116
Closed
57
Calls
$127M
Puts
$105M
Net Calls
+$21.9M
Net Calls Change
-$39.1M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$249M |
| 2 |
Two Sigma Investments
New York
|
+$53.4M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$41.8M |
| 4 |
Millennium Management
New York
|
+$18.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.1M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$248M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$40.2M |
| 3 |
Squarepoint
New York
|
-$22.5M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$21.8M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$14.5M |
